BMT CLUSTER
1BMT cluster
1
PharM clusTers in leading counTries
UK11 largest clusters
Russia7 largest clusters
Germany28 largest clusters
USA15 largest clusters
France18 largest clusters
Japan28 largest clusters
Netherlands5 largest clusters
2
gloBal MarkeTs. BioMedical Technologies
Compound Annual Growth Rate (till 2020)
Market volume
The main segments
2011
2015
2020
clinical medicine and healthcare
Biomedical and life science
Bio-informatics
Industrial bio-techInternational
russian
International
russian
320$ bn
750$ bn
3$ bn
14$ bn
8%14%
133,8 $ bn
264 $ bn
76 $ bn
2,7 $ bn
3
key acTiviTies
To build the viable and self-regulating ecosystem, favorable for business• To attract innovative companies for Skolkovo participation
• Create and support international expert panel
• Financial support for the Participants
• Attract investors
• Create and support infrastructure(Centers of shared facilities (CSF) and Centers of applied research(CAR)
• Support educational platforms
4
key eleMenTs of The ecosysTeM
ecOsystem
educational environment
Regulatory environment
Institutes of commerciali-
zation
clustercommunity
Infrastructures
4
3
2
1
32
1
54
5
•Educationalprograms(openlectures)•Foresightseminars•Internships•Conferences
•CentersforSharedFacilities(CSF)•CentersofAppliedResearch(CAR)•R&Dcenters.Keypartners
•residents•investors•universities•ministries•regionalclusters•expertpanel
•Businessincubators•Venturecapitalfunds•Strategicindustrialinvestors•Institutionalpartners
•Seminarsforresidents (tax,legal,customs,IP, project wrapping consultations)
5
clusTer sTraTegy
companies
Infrastructures
2011 2012 2013 2014
ResIdents
GRants (mln)
csF/caR
R & d centeRs wIth key paRtneRs
2 5
1
8
3
100
$53
150
$90
200
$300
cO-Investments (mln) $21 $36 $120
6
ProjecTs. resulTs 2010-2011
OutsIde Investments
mInI-GRants
GRants
FIRst tRanchs
87
$ 76 mln
$ 32 mln
$ 49 mln
$ 0,15 mln
appr
oved
quan
tity
th
e to
tal
amou
nt
the
tota
l am
oun
tth
e to
tal
amou
nt
RESIDENTS
15 PaRTIcIPaNTS
7
ImagINg
Planned csf/car
PRE-clINIcal RESEaRch. glP STaNDaRDS
REgENERaTIvE mEDIcINE aND cEll TEchNology
SySTEm bIoINfoRmaTIcS
STRucTuRal bIology. mEmbRaNE PRoTEIN aND ThEIR comPlExES
PRoTEomIcS aND mETabolomIocS
NuclEaR mEDIcINE
SyNThETIc bIology
cSf/caR
8
foresighTs of clusTer BMT
•Newhealthcaremethods and technologies targeting the «big killers“
•Personalizedmedicine
•Preventivemedicine
•ITinClinicalMedicine
•Medicalequipment,devices, implants and materials
•NuclearMedicine
•Highthroughputdataanalysis
•Computeraideddrugdesign
•Imageanalysis
•Systemsbiology
•Bio-remediationandbio-degradation
•Ecology
•Industrialdrug-productiontechnologies\
•foodsecurity
•Novelpharmaceuticals
•Newdrugdeliverysystems
•Newtargetsfortreatment
•Pre-clinincaldevelopment and trials
•Moleculardiagnostics
clInIcal medIcIne and healthcaRe BIO-InFORmatIcs
BIOmedIcal and lIFe scIencesw
IndustRIal BIO-tech
9
MInIstry and prIvate Investors
“skolkovo” unIversIty BIoMedIcal faculty
russIan partners: the unIversItIes and he r&d centers
foreIgn unIversIty partners
educaTional environMenT
OPEN lECTuRES
SEMINARSPOSTSATRuSSIANWIKIPEDIA
CONFERENCES
10
ParTners
INVESTORS PARTNERS
R&DCENTERS. KEyPARTNERSR&D
CENTERS. KEyPARTNERS
REIONAlPARTNERSVENTuREFuNDS
PRIVATEINVESTORS ANDBANKS
BIgPHARMCOMPANIES
gOVERMENTORgANIzATIONS
FOREIgNPARTNERS
11
DIRECTORFOREDuCATIONANDSCIENCE
Janssen chRIs
DIRECTORFORINVESTMSNTSANDDEVElOPMENT
kOmOlOv andRey
clusTer BMT (2012)
CluSTER ExECuTIVEDIRECTOR
GORyanIn IGOR
Contacts:kolomenskaya polina
kazbekova victoria
Krasnopresnenskayanaberezhnaya,12, Entrance№9,Floor24, Moscow,123610
Тел.:+7(495)9670148(ex.2114/2364) Факс:+7(495)9670196
e-mail:[email protected] www.sk.ru